February 13th 2025
A study finds that esketamine during cesarean delivery may reduce postpartum depression risk, though further research is needed to confirm its safety and efficacy.
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings
View More
Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine
View More
Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine
View More
Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances
View More
Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer
View More
Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials
View More
Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care
View More
Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations
View More
Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment
View More
Data Reassures of the Probable Safety of SSRIs in Pregnancy
April 3rd 2013There is no association between in utero exposure to selective serotonin reuptake inhibitors (SSRIs) and stillbirth, neonatal mortality, and infant growth rate during the first year of life, according to the results of 2 unrelated studies.
Read More
What to do when patients request cesareans
March 28th 2013Physicians should recommend that their patients plan for vaginal deliveries rather than cesarean deliveries if there are no maternal or fetal indications for a cesarean. This is the position stated in a new committee opinion from the American College of Obstetricians and Gynecologists (ACOG) Committee on Obstetric Practice.
Read More
Evidence Doesn’t Support a 1-step Approach to Diagnosing Gestational Diabetes
March 27th 2013An independent panel convened by the National Institutes of Health has concluded that there is insufficient evidence to adopt a 1-step approach to the diagnosis of gestational diabetes mellitus (GDM).
Read More
Is Fertility Improved After Hysteroscopy for Uterine Cavity Abnormalities?
March 22nd 2013Hysteroscopic removal of polyps in women with unexplained infertility may increase their chances of becoming pregnant, concludes an intervention review conducted by the Cochrane Menstrual Disorders and Subfertility Group.
Read More
Adhesive Surgical Drapes May Cause, Not Prevent, Infection
March 13th 2013There is no evidence that plastic adhesive surgical drapes reduce surgical site infection rates, and some evidence that these drapes may increase infection rates, according to a third update of an intervention review and analysis conducted by the Cochrane Wounds Group.
Read More
Low Levels of Vitamin D, Trace Elements Linked to Premature Ovarian Failure
March 11th 2013Vitamin D deficiencies are common in women with primary ovarian insufficiency (POI), and serum levels of zinc, copper, and vitamin D appear to correlate with hormonal status, concluded a recent cross-sectional, case-control study.
Read More
Anti-D: Does Method of Administration Make a Difference?
March 8th 2013Intramuscular anti-D and intravenous anti-D administered in the 28th week of pregnancy are equally effective for the prevention of Rhesus alloimmunization during pregnancy, according to a new intervention review conducted by the Cochrane Pregnancy and Childbirth Group.
Read More
Around-the-clock labor and delivery model compared with on-call coverage
March 1st 2013A study presented on February 16 at the Society for Maternal-Fetal Medicine (SMFM) annual meeting in San Francisco, California, found that around-the-clock labor and delivery (L & D) coverage decreased the odds of cesarean delivery in certain populations of patients in California.
Read More
Efficacy of Quick Start Hormonal Contraception
March 1st 2013Immediate start of hormonal contraception may reduce unintended pregnancies and increase method continuation, but the evidence is limited, according to the findings of an intervention review conducted by the Cochrane Fertility Regulation Group.
Read More
Poll: Is Terminating a Down Syndrome Fetus the Same as Gendercide?
February 26th 2013Between 70 and 90 percent of women carrying a fetus diagnosed in utero with Down syndrome choose to abort. Is terminating a fetus diagnosed with Down syndrome the same as terminating a fetus because of its gender?
Read More
Internal Versus External Tocodynamometry: Which Has Better Outcomes?
February 25th 2013Monitoring uterine contractions with internal tocodynamometry (IT) versus external tocodynamometry (ET) results in similar maternal and neonatal outcomes in women whose labor is induced or augmented with oxytocin.
Read More
Vaginal Delivery Is Best for Patients With Pelvic Girdle Pain
February 15th 2013Patients with pelvic girdle pain during pregnancy who had a cesarean section were more likely to experience persistent pain 6 months after delivery than patients who delivered vaginally, according to a new follow-up study from the Norwegian Institute of Public Health.
Read More
The Most Hotly Anticipated Ob/Gyn Research of 2013
February 14th 2013New drugs, new research, new guidelines… there’s a lot for ob/gyns to look forward to in the coming year. Here, the leaders of seven ob/gyn societies share the most interesting, important, exciting things on their radar for 2013.
Read More
The Leadership Report: The Best Ob/Gyn Research From 2012
February 14th 2013From ASRM’s removal of the ‘experimental’ label from the procedure of oocyte cryopreservation, to discoveries into the complex genetic processes involved in ovarian cancer, 2012 was another important year in ob/gyn research. Here, the leaders of seven major ob/gyn societies reflect on the most exciting research of the last year.
Read More